Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, germinoma, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, seminoma, testicular cancer, testicular disorder	Recruiting	Not applicable	2026-03-27		NCT07498959

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Haukeland University Hospital	163
Karolinska University Hospital	181
Lund University Hospital	32
Oslo University Hospital	327
Sahlgrenska University Hospital	158
Trondheim University Hospital	8
University Hospital of North Norway	93
University Hospital, Umeå	32
Uppsala University Hospital	80

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sahlgrenska University Hospital	Gothenburg	Sweden	3